y 27632 has been researched along with diamide in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (diamide) | Trials (diamide) | Recent Studies (post-2010) (diamide) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 1,170 | 0 | 294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowles, EA; Ellsworth, ML; Sprague, RS; Stephenson, AH; Thuet, KM | 1 |
1 other study(ies) available for y 27632 and diamide
Article | Year |
---|---|
The Rho kinase inhibitor Y-27632 increases erythrocyte deformability and low oxygen tension-induced ATP release.
Topics: Adenosine Triphosphate; Amides; Cell Hypoxia; Cross-Linking Reagents; Diamide; Erythrocyte Deformability; Erythrocytes; Humans; Intercellular Signaling Peptides and Proteins; Oxygen; Peptides; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Sulfhydryl Reagents; Wasp Venoms | 2011 |